GBA Key2Compliance AB is pleased to announce the appointment of Camilla Oldgren as its new Chief Executive Officer (CEO), effective June 1, 2025.

Camilla brings over 30 years of experience in the life sciences industry, with deep expertise in pharmaceuticals, medical devices, and consulting services. Her professional journey spans executive leadership in established companies as well as advisory roles helping businesses navigate growth and transformation.

HPLC Chemical Characterization – Compliant and Precise GBA Medical Device Services, a part of GBA Group, is excited to announce the expansion of its service portfolio to include high-performance liquid chromatography (HPLC) analyses for the characterization of non-volatile organic compounds (NVOC).

The GBA Group is expanding its international laboratory network and is represented in Switzerland for the first time with the addition of laboratory service provider NIUTEC AG (NIUTEC). With this acquisition, the GBA Group is once again strengthening its positioning in the growing market for the qualification of medical devices. Furthermore, the partnership with NIUTEC creates a strong basis for further development in the important local Swiss market for environmental analysis.

The GBA Group is continuing its international growth strategy by acquiring the Dutch company BAAT Holding B.V. (BAAT Medical), a leading provider of design and development services for medical devices. With this strategic acquisition, the GBA Group strengthens its position in the European medical device market, among other things by expanding its service portfolio in the development phase from the product idea to product development and successful market launch.

GBA Medical Device Services now has an updated GLP (Good Laboratory Practice) certificate following the successful move to a new, state-of-the-art laboratory. This means that we are still ideally positioned to meet your requirements even more flexibly, efficiently and with the highest quality standards.